Chiral primary amino silyl ether organocatalyst for the enantioselective diels-alder reaction of 1,2-dihydropyridines with aldehydes

Heterocycles

Volumn 86, Issue 2, 2012, Pages 1379-1389

  Sakuta, Yuki ^a   Kohari, Yoshihito ^a   Hutabarat, N D M Romauli ^a   Uwai, Koji ^a   Kwon, Eunsang ^b   Okuyama, Yuko ^c   Seki, Chigusa ^a   Matsuyama, Haruo ^a   Takano, Nobuhiro ^a   Tokiwa, Michio ^d   Takeshita, Mitsuhiro ^d   Nakano, Hiroto ^a  

^a MURORAN INSTITUTE OF TECHNOLOGY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^d Tokiwakai Group Tokiwa Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880616137     PISSN: 03855414     EISSN: 18810942     Source Type: Journal    
DOI: 10.3987/COM-12-S(N)93     Document Type: Article

References (24)

1. J. Seayad and B. List, Org. Biomol. Chem, 2005, 3, 719;
2. P. I. Dalko and L. Moisan, Angew. Chem. Int. Ed., 2004, 43, 5138;
3. W. Notz, F. Tanaka, and C. F. Barbas, III, Acc. Chem. Res., 2004, 37, 580;
4. B. List, Synlett, 2001, 1675;
5. L.-W. Xu, J. Luo, and Y. Lu, Chem. Commun., 2009, 1807;
6. L.-W. Xu, L. Li, and Z.-H. Shi, Adv. Synth. Catal., 2010, 352, 243;
7. H. Pellissier, Tetrahedron, 2012, 68, 2197.
8. C. Suttibut, Y. Kohari, K. Igarashi, H. Nakano, M. Hirama, C. Seki, H. Matsuyama, K. Uwai, N. Takano, Y. Okuyama, K. Osone, M. Takeshita, and E. Kwon, Tetrahedron Lett., 2011, 52, 4745;
9. H. Nakano, K. Osone, M. Takeshita, E. Kwon, C. Seki, H. Matsuyama, N. Takano, and Y. Kohari, Chem. Commun., 2010, 46, 4827.
10. N. Takenaka, Y. Huang, and V. H. Rawal, Tetrahedron, 2002, 58, 8299;
11. H. Nakano, N. Tsugawa, and R. Fujita, Tetrahedron Lett., 2005, 46, 5677;
12. H. Nakano, N. Tsugawa, K. Takahashi, Y. Okuyama, and R. Fujita, Tetrahedron, 2006, 62, 10879.
13. P. Popik and P. Skolnick, in Pharmacology of Ibogaine and Ibogaine-related Alkaloids. The Alkaloids. Chemistry and Biology, ed. by G. A. Cordell, Academic: San Diego, 1999, Vol. 52, 197;
14. S. D. Glick, I. M. Maisonneuve, and K. K. Szumlinski, in Mechanisms of Action of Ibogaine: Relevance to Putative Therapeutic Effects and Development of a Safer Iboga Alkaloid Congener. The Alkaloids, ed. by K. R. Alper, S. D. Glick, and G. A. Cordell, Academic: San Diego, 2001, Vol. 56, 39.
15. G. Büchi, D. L. Coffen, K. Kocsis, P. E. Sonnet, and F. E. Ziegler, J. Am. Chem. Soc., 1966, 88, 3099;
16. S. Raucher, B. L. Bray, and R. F. Lawrence, J. Am. Chem. Soc., 1987, 109, 442;
17. M. T. Reding and T. Fukuyama, Org. Lett., 1999, 1, 973.
18. D. Y. He, N. N. McGough, A. Ravindranathan, J. Jeanblanc, M. L. Logrip, K. Phamluong, P. H. Janak, and D. Pon, J. Neurosci., 2005, 25, 619.
19. N. Satoh, T. Akiba, S. Yokoshima, and T. Fukuyama, Tetrahedron, 2009, 65, 3239.
20. Y. Hayashi, T. Itoh, and H. Ishikawa, Angew. Chem. Int. Ed., 2011, 50, 3920.
21. K. Ishihara and K. Nakano, J. Am. Chem. Soc., 2005, 127, 10504;
22. A. Sakakura, K. Suzuki, K. Nakano, and K. Ishihara, Org. Lett., 2006, 8, 2229;
23. K. Ishihara, K. Nakano, and M. Akakura, Org. Lett., 2008, 10, 2893;
24. A. Sakakura, H. Yamada, and K. Ishihara, Org. Lett., 2012, 14, 2972.